4P41 Stock Overview
Develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 4P41 from our risk checks.
Surgical Science Sweden AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr11.32 |
| 52 Week High | kr21.20 |
| 52 Week Low | kr9.99 |
| Beta | 0.93 |
| 11 Month Change | -6.37% |
| 3 Month Change | -7.59% |
| 1 Year Change | -43.57% |
| 33 Year Change | -25.03% |
| 5 Year Change | n/a |
| Change since IPO | -9.80% |
Recent News & Updates
Recent updates
Shareholder Returns
| 4P41 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -5.7% | -3.8% | -0.6% |
| 1Y | -43.6% | -0.8% | 2.9% |
Return vs Industry: 4P41 underperformed the German Medical Equipment industry which returned -0.8% over the past year.
Return vs Market: 4P41 underperformed the German Market which returned 2.9% over the past year.
Price Volatility
| 4P41 volatility | |
|---|---|
| 4P41 Average Weekly Movement | 6.6% |
| Medical Equipment Industry Average Movement | 4.7% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.7% |
| 10% least volatile stocks in DE Market | 2.6% |
Stable Share Price: 4P41 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4P41's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 265 | Gisli Hennermark | www.surgicalscience.com |
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room.
Surgical Science Sweden AB (publ) Fundamentals Summary
| 4P41 fundamental statistics | |
|---|---|
| Market cap | €588.98m |
| Earnings (TTM) | €18.49m |
| Revenue (TTM) | €74.88m |
31.9x
P/E Ratio7.9x
P/S RatioIs 4P41 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4P41 income statement (TTM) | |
|---|---|
| Revenue | kr842.02m |
| Cost of Revenue | kr264.50m |
| Gross Profit | kr577.52m |
| Other Expenses | kr369.57m |
| Earnings | kr207.95m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 22, 2024
| Earnings per share (EPS) | 4.08 |
| Gross Margin | 68.59% |
| Net Profit Margin | 24.70% |
| Debt/Equity Ratio | 0% |
How did 4P41 perform over the long term?
See historical performance and comparison